Table 1. Clinical characteristics of studied patients.
| Parameters | Total (n = 28) | Tel group (n = 14) | Val group (n = 14) |
|---|---|---|---|
| Age (years) | 58 ± 9 | 57 ± 7 | 60 ± 10 |
| BMI (kg/m2) | 26.7 ± 3.3 | 26.9 ± 3.7 | 26.6 ± 3.0 |
| T cholesterol (mg/dL) | 203 ± 35 | 216 ± 27 | 190 ± 37 |
| TG (mg/dL) | 155 ± 112 | 132 ± 110 | 178 ± 112 |
| HDL Chol (mg/dL) | 46 ± 14 | 46 ± 15 | 46 ± 14 |
| HbA1c (%) | 6.9 ± 1.2 | 6.9 ± 1.3 | 6.9 ± 1.2 |
| Scr (mg/dL) | 0.81 ± 0.12 | 0.81 ± 0.13 | 0.82 ± 0.12 |
| eGFR (mL/min/1.73 m2) | 73 ± 12 | 71 ± 9 | 69 ± 6 |
| PDMP (U/mL) | 14.0 ± 7.8 | 15.5 ± 9.1 | 12.7 ± 6.2 |
| ACR (mg/g Cr) | 40 (11–145) | 52 (11–237) | 30 (111–84) |
Data are expressed as the mean ± SD or the number of patients. The ACR was logarithmically transformed and is presented as the geometric means with their 95% confidence intervals. Tel; Telmisartan; Val; valsartan; BMI, body mass index; T, total; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; ACR, albumin/creatinine excretion ratio; PDMP, platelet‐derived microparticles. *P < 0.05 vs baseline.